These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5520604)

  • 1. Effects of the 1-keto and 1-hydroxy derivatives of 3-methylcholanthrene upon liver drug metabolizing enzyme activity.
    Bresnick E; Smith S; Seibert RA
    Biochem Pharmacol; 1970 Aug; 19(8):2469-74. PubMed ID: 5520604
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of dibromotetrafluoroethane inhalation on hepatic drug metabolism in mice.
    Murphy JP; Van Stee EW; Back KC
    Biochem Pharmacol; 1973 Nov; 22(22):2843-51. PubMed ID: 4761555
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatic drug metabolism after phenobarbital or 3-methylcholanthrene pretreatment of rats bearing a pituitary tumor.
    Wilson JT
    Proc Soc Exp Biol Med; 1968 Jun; 128(2):445-8. PubMed ID: 5663252
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of inducers and inhibitors of mixed-function oxidasts on benzo(a)pyrene binding to the DNA of rat liver nuclei.
    Alexandrov K; Thompson MH
    Cancer Res; 1977 May; 37(5):1443-9. PubMed ID: 856463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the kinetics of benzpyrene hydroxylation by hepatic drug-metabolizing enzymes from phenobarbital and 3-methylcholanthrene-treated rats.
    Alvares AP; Schilling GR; Kuntzman R
    Biochem Biophys Res Commun; 1968 Mar; 30(5):588-93. PubMed ID: 5645445
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic expression of aryl hydrocarbon hydroxylase induction. Presence or absence of association with zoxazolamine, diphenylhydantoin, and hexobarbital metabolism.
    Robinson JR; Nebert DW
    Mol Pharmacol; 1974 May; 10(3):484-93. PubMed ID: 4852151
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of benzpyrene-hydroxylase activity in fetal rat liver explants. I. Metabolism of 3-methylcholanthrene and differential effects of its derivatives on benzpyrene-hydroxylase activity.
    Bürki K; Seibert RA; Bresnick E
    Biochim Biophys Acta; 1972 Jan; 260(1):98-109. PubMed ID: 5062445
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of pretreatment of rabbits with phenobarbital or 3-methylcholanthrene on the distribution of drug-metabolizing enzyme activity in subfractions of hepatic microsomes.
    Gram TE; Rogers LA; Fouts JR
    J Pharmacol Exp Ther; 1967 Aug; 157(2):435-45. PubMed ID: 6039834
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of acetaminophen on liver microsomal drug-metabolizing enzyme in vitro in mice.
    Aikawa K; Satoh T; Kitagawa H
    Biochem Pharmacol; 1977 May; 26(9):893-5. PubMed ID: 861056
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies of 3,4-benzpyrene, 3-methylcholanthrene, chlordane, and methyltestosterone as stimulators of hepatic microsomal enzyme systems in the rat.
    Mullen JO; Juchau MR; Fouts JR
    Biochem Pharmacol; 1966 Feb; 15(2):137-44. PubMed ID: 4380232
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative metabolism of benzo[a]pyrene and drugs in human liver.
    Kapitulnik J; Popper PJ; Conney AH
    Clin Pharmacol Ther; 1977 Feb; 21(2):166-76. PubMed ID: 837635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of in vivo zoxazolamine metabolism by carbon monoxide in normal and polycyclic hydrocarbon-treated immature male rats.
    Krevsky B; Hitchcock M
    Drug Metab Dispos; 1977; 5(5):451-3. PubMed ID: 20293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some problems in Michaelis-Menten kinetic analysis of benzpyrene hydroxylase in hepatic microsomes from polycyclic hydrocarbon-pretreated animals.
    Hansen AR; Fouts JR
    Chem Biol Interact; 1972 Aug; 5(3):167-82. PubMed ID: 5047750
    [No Abstract]   [Full Text] [Related]  

  • 14. Alteration of the microsomal hemoprotein by 3-methylcholanthrene: effects of ethionine and actinomycin D.
    Alvares AP; Schilling G; Levin W; Kuntzman R
    J Pharmacol Exp Ther; 1968 Oct; 163(2):417-24. PubMed ID: 5681181
    [No Abstract]   [Full Text] [Related]  

  • 15. Lithium-induced increase in the metabolism of benzo[a]pyrene and drugs in rat liver.
    Feuerstein G; Govrin H; Kapitulnik J
    Biochem Pharmacol; 1979 Nov; 28(21):3167-70. PubMed ID: 118760
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of enzyme induction on the metabolism of benzo(a)pyrene and 3'-methyl-4-monomethylaminoazobenzene in the pregnant and fetal rat.
    Welch RM; Gommi B; Alvares AP; Conney AH
    Cancer Res; 1972 May; 32(5):973-8. PubMed ID: 5017744
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition by aflatoxin B1 of rat liver zoxazolamine hydroxylase induction.
    Pong RS; Wogan GN
    Biochem Pharmacol; 1970 Oct; 19(10):2808-12. PubMed ID: 5478589
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of riboflavin deficiency on phenobarbital and 3-methylcholanthrene induction of microsomal drug-metabolizing enzymes of the rat.
    Shargel L; Mazel P
    Biochem Pharmacol; 1973 Oct; 22(19):2365-73. PubMed ID: 4147670
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of 3-methylcholanthrene and some related compounds upon the benzpyrene hydroxylase activity in fetal rat liver explants.
    Bürki K; Seibert RA; Bresnick E
    Biochem Pharmacol; 1971 Nov; 20(11):2947-52. PubMed ID: 5132103
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the O-dealkylation of 7-ethoxycoumarin and the hydroxylation of benzo(a)pyrene in human placenta. Effect of cigarette smoking.
    Jacobson M; Levin W; Poppers PJ; Wood AW; Conney AH
    Clin Pharmacol Ther; 1974 Oct; 16(4):701-10. PubMed ID: 4417865
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.